Halozyme has completed its acquistion of Antares Pharma, creating a leading drug delivery business. View details here.
For InvestorsAntares Pharma: Making Medicines Feel Better

SEC Filings

Search By Keyword:
Filter By Year:
Filter By Type:
Showing 101 to 150 of 619
Date Title Type
2003-02-18424B3 - Prospectus [Rule 424(b)(3)]424B3
2003-02-208-K - Current report8-K
2003-03-1810-Q/A [Amend] - Quarterly report [Sections 13 or10-Q/A
2003-03-21S-3 - Registration statement under Securities ActS-3
2003-03-2110-K - Annual report [Section 13 and 15(d), not S10-K
2003-03-258-K - Current report8-K
2003-03-27PRE 14A - Other preliminary proxy statementsPRE 14A
2003-04-10DEF 14A - Other definitive proxy statementsDEF 14A
2003-05-018-K - Current report8-K
2003-05-15NT 10-Q - Notification of inability to timely filNT 10-Q
2003-05-2010-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2003-05-22S-3/A [Amend] - Registration statement under SecuS-3/A
2003-05-27424B3 - Prospectus [Rule 424(b)(3)]424B3
2003-05-298-K - Current report8-K
2003-06-058-K - Current report8-K
2003-06-308-K - Current report8-K
2003-07-098-K - Current report8-K
2003-07-15REGDEX [Paper] - Notice of Sale of Securities [RegREGDEX
2003-07-18SC 13D - General statement of acquisition of beneSC 13D
2003-07-21SC 13G - Statement of acquisition of beneficial oSC 13G
2003-07-228-K - Current report8-K
2003-07-24SC 13G - Statement of acquisition of beneficial oSC 13G
2003-08-1410-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2003-09-158-K - Current report8-K
2003-09-188-K - Current report8-K
2003-09-25S-2 - Registration of securitiesS-2
2003-10-01424B3 - Prospectus [Rule 424(b)(3)]424B3
2003-10-08DEF 14A - Other definitive proxy statementsDEF 14A
2003-10-10DEFR14A - Revised definitive proxy soliciting matDEFR14A
2003-11-1410-Q - Quarterly report [Sections 13 or 15(d)]10-Q
2003-12-15S-8 - Securities to be offered to employees in emS-8
2004-01-12SC 13D/A [Amend] - General statement of acquisitiSC 13D/A
2004-02-06SC 13G - Statement of acquisition of beneficial oSC 13G
2004-02-06SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2004-02-108-K - Current report8-K
2004-02-12SC 13G - Statement of acquisition of beneficial oSC 13G
2004-02-13SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2004-02-238-K - Current report8-K
2004-02-25REGDEX [Paper] - Notice of Sale of Securities [RegREGDEX
2004-03-02REGDEX/A [Amend] [Paper] - Notice of Sale of SecurREGDEX/A
2004-03-108-K - Current report8-K
2004-03-12SC 13D/A [Amend] - General statement of acquisitiSC 13D/A
2004-03-3010-K - Annual report [Section 13 and 15(d), not S10-K
2004-03-31S-2 - Registration of securitiesS-2
2004-04-018-K/A [Amend] - Current report8-K/A
2004-04-14424B3 - Prospectus [Rule 424(b)(3)]424B3
2004-04-21SC 13G/A [Amend] - Statement of acquisition of beSC 13G/A
2004-05-0410-K/A [Amend] - Annual report [Section 13 and 1510-K/A
2004-05-12DEF 14A - Other definitive proxy statementsDEF 14A
2004-05-1410-Q - Quarterly report [Sections 13 or 15(d)]10-Q
Showing 101 to 150 of 619